Jiaxi Wang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Journal: Frontiers in immunology
Published: September 04, 2024
Phase I Clinical Trial of CD19 CAR-T Cells Expressing CXCR5 Protein for the Treatment of Relapsed or Refractory B-cell Lymphoma.
Journal: Current cancer drug targets
Published: February 09, 2024
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.
Journal: Leukemia
Published: December 07, 2023
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
Journal: Frontiers in immunology
Published: January 07, 2023
Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies.
Journal: Technology in cancer research & treatment
Published: August 22, 2022
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia.
Journal: Journal of hematology & oncology
Published: June 01, 2022
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure.
Journal: Infection and drug resistance
Published: March 01, 2022
Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.
Journal: BMC medical genomics
Published: January 16, 2022
Optimization of metabolism to improve efficacy during CAR-T cell manufacturing.
Journal: Journal of translational medicine
Published: August 24, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026